Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924Cora N. Sternberg, Laurence Collette, Fred Witjes et al.|Journal of Clinical Oncology|2001Cited by 628
High-Dose Therapy and Autologous Peripheral-Blood Stem-Cell Transplantation As Salvage Treatment for HIV-Associated Lymphoma in Patients Receiving Highly Active Antiretroviral TherapyAlessandro Re, Giuseppe Rossi, Chiara Cattaneo et al.|Journal of Clinical Oncology|2003Cited by 129
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Marco Ladetto, Simone Ferrero et al.|Cancers|2021Cited by 13